Plain-English translation of NCT07459907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is designed to follow pregnant women who have been diagnosed with gestational diabetes—a type of diabetes that develops during pregnancy—from diagnosis through the first few months after birth. Researchers will collect medical information, physical measurements, and biological samples (like placental tissue and cord blood) at multiple visits to better understand how gestational diabetes affects both mother and baby immediately and in the long term.
Gestational diabetes can increase health risks for both mothers and babies during and after pregnancy, but doctors still don't fully understand why it happens or how to best predict and prevent long-term health problems. This study aims to fill that gap by gathering detailed information that could lead to better care and prevention strategies in the future.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic four times: shortly after your gestational diabetes diagnosis (around weeks 26-30 of pregnancy), again in late pregnancy (weeks 34-37), at the time of delivery, and once more about 8-12 weeks after your baby is born. At each visit, the team will take measurements (like weight and blood pressure), perform routine ultrasounds, collect blood work, and ask you questions about your health. At delivery, researchers will also collect samples of placental tissue and cord blood.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Austria